Skip to main content
Log in

CME-Beitrag

Multiple Sklerose — Ursache, Diagnose, Verlauf und Therapie

  • Fortbildung
  • Published:
Zeitschrift für Allgemeinmedizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Operskalski EA, Visscher BR, Malmgren RM, et al. A case-control study of multiple sclerosis. Neurology 1989; 29: 825–829

    Article  Google Scholar 

  2. Ascherio A, Munger KL, Lennette RT, et al. Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis — a prospective Study. JAMA 2001; 286: 3083–3088

    Article  CAS  PubMed  Google Scholar 

  3. Wandinger KP, Jabs W, Siekhaus A, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000; 55: 178–185

    Article  CAS  PubMed  Google Scholar 

  4. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Annals of Neurology 2004; 55: 458–468

    Article  PubMed  Google Scholar 

  5. Weihe W, Manke A, Gowin W, et al. Die prognostische Bedeutung von lakunären Herden im magnetischen Resonanztomogramm bei Multipler Sklerose. Nervenarzt 1988; 59: 14–18

    CAS  PubMed  Google Scholar 

  6. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographical based study: I. Clinical course and disability. Brain 1989; 112: 133–146

    Article  PubMed  Google Scholar 

  7. Pittock SJ, Maye WT, McClelland RL, et al. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 2004; 62: 51–59

    Article  CAS  PubMed  Google Scholar 

  8. Noort JM van, Sechel AC van, Bajramovic JJ, et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995; 29: 798–801

    Article  Google Scholar 

  9. Mohr DC, Goodkin DE, Bacchetti P, et al. Psychological stress and the subsequent appearance of new brain MRI lesons in MS. Neurology 2000; 55: 55–61

    Article  CAS  PubMed  Google Scholar 

  10. Diem R, Hobom M, Maier K, et al. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neuroscience 2005; 23: 6993–7000

    Article  Google Scholar 

  11. MS-Therapie Konsensus Gruppe (MSTKG). Immunmodulatorische Stufentherapie der multiplen Sklerose. Nervenarzt 1999; 70: 371–386

    Article  Google Scholar 

  12. Rice GPA, Incorvaim B, Munari L, et al. Interferon in relapsing-remitting multiple sclerosis (Cochrane Review). In: Issue 3. The Cochrane Library 2004

  13. Munari L, Lovati R, Boiko A, et al. Therapy with glatiramer acetate for multiple sclerosis (Cochrane Review). In: Issue 3. The Cochrane Library 2004

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang Weihe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weihe, W. CME-Beitrag. Z Allg Med 81, 205–215 (2005). https://doi.org/10.1007/BF03652152

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03652152

Navigation